Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI

Journal of Magnetic Resonance Imaging

Volumn 31, Issue 3, 2010, Pages 562-570

  Partridge, Savannah C ^a   DeMartini, Wendy B ^a   Kurland, Brenda F ^b   Eby, Peter R ^a   White, Steven W ^a,c   Lehman, Constance D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

^c University of Washington   (United States)

Author keywords

Apparent diffusion coefficient (ADC); Benign lesions; Breast cancer; Diffusion weighted imaging (DWI); Mammographically occult; Nonpalpable

Indexed keywords

GADODIAMIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BREAST; BREAST FIBROADENOMA; BREAST FIBROSIS; BREAST HYPERPLASIA; BREAST LESION; BREAST PSEUDOANGIOMATOUS STROMAL HYPERPLASIA; CANCER INVASION; CANCER SCREENING; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VISIBILITY;

ADULT; AGED; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; YOUNG ADULT;

EID: 77649217569     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22078     Document Type: Article

References (39)

1. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57:75-89.
2. Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007;356:1295-1303.
3. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168:497-505.
4. Matoba M, Tonami H, Kondou T, et al. Lung carcinoma: diffusion-weighted mr imaging - preliminary evaluation with apparent diffusion coefficient. Radiology 2007;243:570-577.
5. Mazaheri Y, Shukla-Dave A, Hricak H, et al. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging - correlation with pathologic findings. Radiology 2008;246:480-488.
6. Ohno Y, Koyama H, Onishi Y, et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment - utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology 2008;248:643-654.
7. Parikh T, Drew SJ, Lee VS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 2008; 246:812-822.
8. Zhang J, Tehrani YM, Wang L, Ishill NM, Schwartz LH, Hricak H. Renal masses: characterization with diffusion-weighted MR imaging - a preliminary experience. Radiology 2008;247:458-464.
9. Kuroki-Suzuki S, Kuroki Y, Nasu K, Nawano S, Moriyama N, Okazaki M. Detecting breast cancer with non-contrast MR imaging: combining diffusion-weighted and STIR imaging. Magn Reson Med Sci 2007;6:21-27.
10. Park MJ, Cha ES, Kang BJ, Ihn YK, Baik JH. The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol 2007;8: 390-396.
11. Yoshikawa MI, Ohsumi S, Sugata S, et al. Comparison of breast cancer detection by diffusion-weighted magnetic resonance imaging and mammography. Radiat Med 2007;25:218-223.
12. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002;16:172-178.
13. Hatakenaka M, Soeda H, Yabuuchi H, et al. Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci 2008;7:23-29.
14. Kinoshita T, Yashiro N, Ihara N, Funatu H, Fukuma E, Narita M. Diffusion-weighted half-Fourier single-shot turbo spin echo imaging in breast tumors: differentiation of invasive ductal carcinoma from fibroadenoma. J Comput Assist Tomogr 2002;26: 1042-1046.
15. Marini C, Iacconi C, Giannelli M, Cilotti A, Moretti M, Bartolozzi C. Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol 2007;17:2646-2655
16. Rubesova E, Grell AS, De Maertelaer V, Metens T, Chao SL, Lemort M. Quantitative diffusion imaging in breast cancer: a clinical prospective study. J Magn Reson Imaging 2006;24:319-324.
17. Sinha S, Lucas-Quesada FA, Sinha U, DeBruhl N, Bassett LW. In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging 2002;15:693-704.
18. Wenkel E, Geppert C, Schulz-Wendtland R, et al. Diffusion weighted imaging in breast MRI: comparison of two different pulse sequences. Acad Radiol 2007;14:1077-1083.
19. Woodhams R, Matsunaga K, Kan S, et al. ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 2005;4: 35-42.
20. Yabuuchi H, Matsuo Y, Okafuji T, et al. Enhanced mass on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusionweighted MR images. J Magn Reson Imaging 2008;28:1157-1165.
21. Lo GG, Ai V, Chan JK, et al. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T. J Comput Assist Tomogr 2009;33:63-69.
22. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292:1317-1325.
23. Lehman CD, Isaacs C, Schnall MD, et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multiinstitution breast cancer screening study. Radiology 2007;244: 381-388.
24. Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005;365:1769-1778.
25. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351:427-437.
26. American College of Radiology (ACR). Breast imaging reporting and data system atlas (BI-RADS Atlas). Reston, VA; 2003.
27. Kumar R, Asmuth JC, Hanna K, et al. Application of 3D registration for detecting lesions in magnetic resonance breast scans. In: Proc SPIE, 1996.
28. Gonen M, Panageas KS, Larson SM. Statistical issues in analysis of diagnostic imaging experiments with multiple observations per patient. Radiology 2001;221:763-767.
29. Box GEP, Cox DR. An analysis of transformations. J R Stat Soc Ser B 1964;26:211-246.
30. Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. JAMA 2005;293:1245-1256.
31. Lyng H, Haraldseth O, Rofstad EK. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000; 43:828-836.
32. Sugahara T, Korogi Y, Kochi M, et al. Usefulness of diffusionweighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9:53-60.
33. Matsuoka A, Minato M, Harada M, et al. Comparison of 3.0-and 1.5-Tesla diffusion-weighted imaging in the visibility of breast cancer. Radiat Med 2008;26:15-20.
34. Le Bihan D, Poupon C, Amadon A, Lethimonnier F. Artifacts and pitfalls in diffusion MRI. J Magn Reson Imaging 2006;24:478-488.
35. Mukherjee P, Chung SW, Berman JI, Hess CP, Henry RG. Diffusion tensor MR imaging and fiber tractography: technical considerations. AJNR Am J Neuroradiol 2008;29:843-852.
36. Zhuang J, Hrabe J, Kangarlu A, et al. Correction of eddy-current distortions in diffusion tensor images using the known directions and strengths of diffusion gradients. J Magn Reson Imaging 2006;24:1188-1193.
37. Chen G, Jespersen SN, Pedersen M, Pang Q, Horsman MR, Stodkilde-Jorgensen H. Intravenous administration of Gd-DTPA prior to DWI does not affect the apparent diffusion constant. Magn Reson Imaging 2005;23:685-689.
38. Fitzek C, Mentzel HJ, Fitzek S, Sauner D, Kaiser WA, Reichenbach JR. Echoplanar diffusion-weighted MRI with intravenous gadolinium-DTPA. Neuroradiology 2003;45:592-597.
39. Ogura A, Hayakawa K, Miyati T, Maeda F. The effect of susceptibility of gadolinium contrast media on diffusion-weighted imaging and the apparent diffusion coefficient. Acad Radiol 2008;15: 867-872.